The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy
Sophie R. de Mol van Otterloo(Utrecht University), Helena M. Verkooijen(University Medical Center Utrecht), William A. Hall(Medical College of Wisconsin), Corinne Faivre‐Finn(University of Manchester), Kevin Brown(Elekta (Sweden)), Kristina M. Orrling(Lygature), Arjun Sahgal(Sunnybrook Health Science Centre), Erwin L. A. Blezer(University Medical Center Utrecht), Robbert J.H.A. Tersteeg(University Medical Center Utrecht), Jeffrey G. Sarmiento(The University of Texas MD Anderson Cancer Center), Rob H.N. Tijssen(University Medical Center Utrecht), Martijn Intven(University Medical Center Utrecht), Claire McCann(Siemens Healthcare (United States)), Bradley A. Erickson(Medical College of Wisconsin), Hafid Akhiat(Elekta (Sweden)), Baukelien van Triest(The Netherlands Cancer Institute), S. Hafeez(Institute of Cancer Research), John P. Christodouleas(Elekta (Sweden)), Alison Tree(Royal Marsden NHS Foundation Trust), Ananya Choudhury(University of Manchester), Robert Huddart(Institute of Cancer Research), Susan Lalondrelle(Royal Marsden NHS Foundation Trust), Clifton D. Fuller(The University of Texas MD Anderson Cancer Center), Emma Hall(Institute of Cancer Research), Anna M. Kirby(Royal Marsden NHS Foundation Trust), Stella Mook(Utrecht University), Kevin J. Harrington(Royal Marsden NHS Foundation Trust), Uwe Oelfke(Royal Marsden NHS Foundation Trust), Bruce D. Minsky(The University of Texas MD Anderson Cancer Center), Dave Eggert(Elekta (Sweden)), Joel Goldwein(Elekta (Sweden)), Uulke A. van der Heide(Radboud University Nijmegen), Marlies E. Nowee(The Netherlands Cancer Institute), Christopher J. Schultz(Medical College of Wisconsin)
Cited by 150
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2004|3.2k
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|2.3k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k